Stock Analysis

Discovering Australia's Undiscovered Gems in September 2024

Published

Over the last 7 days, the Australian market has remained flat, though it has risen 10% over the past 12 months. In this stable yet promising environment, identifying stocks with strong growth potential and solid fundamentals becomes crucial for investors seeking to capitalize on forecasted earnings growth of 12% annually.

Top 10 Undiscovered Gems With Strong Fundamentals In Australia

NameDebt To EquityRevenue GrowthEarnings GrowthHealth Rating
Fiducian GroupNA9.94%6.48%★★★★★★
LycopodiumNA17.22%33.85%★★★★★★
Sugar TerminalsNA2.34%2.64%★★★★★★
Bisalloy Steel Group0.95%10.27%24.14%★★★★★★
SKS Technologies GroupNA34.65%47.39%★★★★★★
BSP Financial Group7.53%7.31%4.10%★★★★★☆
Steamships Trading33.60%4.38%3.90%★★★★★☆
AMCILNA5.16%5.31%★★★★★☆
Hearts and Minds Investments1.00%18.81%20.95%★★★★☆☆
A2B Australia15.83%-7.78%25.44%★★★★☆☆

Click here to see the full list of 55 stocks from our ASX Undiscovered Gems With Strong Fundamentals screener.

Underneath we present a selection of stocks filtered out by our screen.

BSP Financial Group (ASX:BFL)

Simply Wall St Value Rating: ★★★★★☆

Overview: BSP Financial Group Limited offers commercial banking and finance services to individual and corporate customers across Papua New Guinea, the Solomon Islands, Fiji, the Cook Islands, Samoa, Tonga, Vanuatu, Cambodia, and Laos with a market cap of A$2.97 billion.

Operations: BSP Financial Group Limited generates revenue primarily from its PNG Bank segment (PGK 2.13 billion) and Pacific Markets segment (PGK 638.68 million), with additional contributions from Non-Bank Entities (PGK 112.27 million).

BSP Financial Group, with total assets of PGK37.4B and equity of PGK4.3B, reported net income for the first half of 2024 at PGK520.46M, up from PGK427.17M last year. Despite a negative earnings growth rate (-11.8%) over the past year, it has a sufficient allowance for bad loans (108%). Total deposits stand at PGK30B while loans are at PGK16.5B; however, it faces high non-performing loans (4%).

ASX:BFL Earnings and Revenue Growth as at Sep 2024

Generation Development Group (ASX:GDG)

Simply Wall St Value Rating: ★★★★★★

Overview: Generation Development Group Limited (ASX:GDG) is an Australian company involved in the marketing and management of life insurance and life investment products and services, with a market cap of approximately A$817.56 million.

Operations: Generation Development Group Limited generates revenue primarily from Benefit Funds (A$316.26 million) and Benefit Funds Management & Funds Administration (A$37.26 million). The company also has smaller revenue streams from Other Business activities (A$3.54 million).

Generation Development Group (GDG) has demonstrated robust financial health with net income rising to A$5.84 million from A$4.48 million year-over-year, reflecting a 30.3% earnings growth that outpaced the Insurance industry’s 25.4%. The company is debt-free and reported basic earnings per share of A$0.0301, up from A$0.0238 previously. Despite significant insider selling in the last quarter, GDG's high-quality earnings and forecasted annual growth rate of 40.99% highlight its promising trajectory in the market.

ASX:GDG Debt to Equity as at Sep 2024

Paragon Care (ASX:PGC)

Simply Wall St Value Rating: ★★★★☆☆

Overview: Paragon Care Limited distributes medical equipment, devices, and consumables to the healthcare markets in Australia, New Zealand, and Asia with a market cap of A$695.23 million.

Operations: Paragon Care Limited generates revenue primarily from the distribution of pharmaceuticals and medical consumables, amounting to A$2187.35 million.

Paragon Care, a small cap healthcare company, has shown impressive earnings growth of 68.4% over the past year, outpacing its industry peers. Despite a high net debt to equity ratio of 335.7%, the company’s interest payments are well covered by EBIT at 4.4x coverage. Trading at 20.2% below its estimated fair value, Paragon Care offers potential upside for investors looking for undervalued stocks in Australia's healthcare sector.

ASX:PGC Earnings and Revenue Growth as at Sep 2024

Key Takeaways

Ready For A Different Approach?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com